acquisition
Allergan eyeing Actavis buyout
November 13, 2014Medical Communications, Research and Development, Sales and Marketing Actavis, Allergan, Botox, Valeant, acquisition, buyout, merger
Allergan is attempting to block a recent Valeant hostile takeover bid by seeking the rumoured alternative merger deal with Actavis, …
Pfizer ‘significantly undervalued’ AstraZeneca
April 29, 2014Sales and Marketing AstraZeneca, Pfizer, acquisition, buyout, merger
AstraZeneca has broken its silence to insist that Pfizer’s financial offer in January for the company “very significantly undervalued AstraZeneca …
Pfizer makes second bid for AstraZeneca
April 28, 2014Research and Development, Sales and Marketing AstraZeneca, Pfizer, acquisition, deal, merger
Pfizer has made a second attempt to buy AstraZeneca after an initial request was rejected in January. The biggest pharma …
Forest sold to Actavis for $25 billion
February 18, 2014Sales and Marketing Actavis, CNS, Forest, acquisition, labs, merger, synergy
The rumours of a substantial deal for Forest have been proven true after Actavis announced this afternoon that it will …
GolinHarris to acquire Virgo HEALTH
July 6, 2012Medical Communications, Sales and Marketing GolinHarris, Med Comms, Virgo HEALTH, acquisition, agency, digital
GolinHarris, a division within Interpublic Group, will acquire the medical communications firm Virgo HEALTH. Virgo HEALTH will retain its name …
Takeda to buy gout specialist URL Pharma for $800m
April 16, 2012Research and Development, Sales and Marketing R&D, Takeda, acquisition, gout
Takeda is set to purchase URL Pharmaceuticals for $800 million, helping offset the loss of its blockbuster ulcer drug Prevacid. …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
